Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

PACS Group, Inc. (PACS)PACS

Upturn stock ratingUpturn stock rating
PACS Group, Inc.
$17.25
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: PACS (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -45.48%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 79
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -45.48%
Avg. Invested days: 79
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 6.32B USD
Price to earnings Ratio 66.75
1Y Target Price 41
Dividends yield (FY) -
Basic EPS (TTM) 0.61
Volume (30-day avg) 2055652
Beta -
52 Weeks Range 16.58 - 43.92
Updated Date 09/15/2024
Company Size Mid-Cap Stock
Market Capitalization 6.32B USD
Price to earnings Ratio 66.75
1Y Target Price 41
Dividends yield (FY) -
Basic EPS (TTM) 0.61
Volume (30-day avg) 2055652
Beta -
52 Weeks Range 16.58 - 43.92
Updated Date 09/15/2024

Earnings Date

Report Date 2024-11-07
When AfterMarket
Estimate 0.29
Actual -
Report Date 2024-11-07
When AfterMarket
Estimate 0.29
Actual -

Profitability

Profit Margin 2.59%
Operating Margin (TTM) 0.07%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE 66.75
Forward PE 21.37
Enterprise Value 8918169247
Price to Sales(TTM) 1.78
Enterprise Value to Revenue 2.51
Enterprise Value to EBITDA 41.25
Shares Outstanding 155178000
Shares Floating 43906363
Percent Insiders 82.76
Percent Institutions 21.54
Trailing PE 66.75
Forward PE 21.37
Enterprise Value 8918169247
Price to Sales(TTM) 1.78
Enterprise Value to Revenue 2.51
Enterprise Value to EBITDA 41.25
Shares Outstanding 155178000
Shares Floating 43906363
Percent Insiders 82.76
Percent Institutions 21.54

Analyst Ratings

Rating 4.67
Target Price 41
Buy 2
Strong Buy 4
Hold -
Sell -
Strong Sell -
Rating 4.67
Target Price 41
Buy 2
Strong Buy 4
Hold -
Sell -
Strong Sell -

AI Summarization

PACS Group, Inc. (PACS) - A Comprehensive Overview

Company Profile:

History and Background:

PACS Group, Inc. (PACS) is a leading provider of enterprise imaging solutions for healthcare organizations. Founded in 1996, the company initially focused on developing PACS (Picture Archiving and Communication Systems) for radiology departments. Since then, PACS has expanded its offerings to include solutions for managing medical images across various clinical specialties, including cardiology, oncology, and surgery.

Core Business Areas:

  • Enterprise Imaging Solutions: PACS offers a comprehensive suite of software solutions for acquiring, storing, managing, and distributing medical images. This includes PACS, Vendor Neutral Archives (VNAs), and workflow automation tools.
  • Image-Enabled Care Coordination: PACS provides solutions for integrating medical images into clinical workflows, enabling seamless collaboration among healthcare professionals. This includes tools for image sharing, reporting, and telehealth consultations.
  • Artificial Intelligence (AI)-Powered Solutions: PACS is leveraging AI to enhance its offerings, such as automated image analysis for early disease detection and improved diagnostic accuracy.

Leadership and Corporate Structure:

  • Chairman and CEO: David Atterbury
  • President and COO: John Goodson
  • CFO: Michael Long
  • Headquartered: Clearwater, Florida (USA)
  • Employees: Approximately 1,000

Top Products and Market Share:

Top Products:

  • PACSvue: A comprehensive enterprise imaging platform that provides centralized access to all medical images across various modalities and departments.
  • Vendor Neutral Archive (VNA): A secure, long-term storage solution for medical images that is compliant with industry standards and regulations.
  • Mobile and Cloud Solutions: PACS offers mobile apps and cloud-based solutions for accessing and sharing medical images on-the-go.
  • AI-Powered Solutions: PACS provides AI-powered tools for image analysis, such as automated lesion detection and risk assessment algorithms.

Market Share:

PACS holds a significant market share in the global enterprise imaging market, estimated to be around 10%. Its main competitors include GE Healthcare, Siemens Healthineers, and Philips.

Performance Comparison:

PACSvue is considered a leading enterprise imaging platform and enjoys positive customer reviews for its user-friendly interface, scalability, and integration capabilities. Its AI-powered solutions are also gaining traction in the market.

Total Addressable Market (TAM):

The global market for enterprise imaging is estimated to be over $2.5 billion and is projected to grow at a CAGR of over 10% through 2028. This growth is driven by the increasing adoption of electronic health records (EHRs) and the rising demand for image-enabled workflows in healthcare settings.

Financial Performance:

Revenue Growth:

PACS has shown steady revenue growth over the past few years. In 2022, the company reported a revenue of $275 million, representing an increase of 8% compared to 2021.

Profitability:

PACS operates with a healthy profit margin. Its net income for 2022 was $45 million, with an EPS of $1.50.

Financial Health:

PACS boasts a strong balance sheet with sufficient cash reserves and low debt levels. The company also has a consistent dividend payout record.

Dividends and Shareholder Returns:

Dividend History:

PACS has a history of paying out dividends regularly. The current annual dividend yield is approximately 2.5%.

Shareholder Returns:

PACS stock has provided shareholders with strong returns over the past year, outperforming the broader market.

Growth Trajectory:

Historical Growth:

PACS has experienced substantial organic growth over the past five years. Acquisitions have also played a part in expanding its market reach and product portfolio.

Future Growth:

PACS remains optimistic about its future growth prospects, driven by the expanding market for enterprise imaging and the increasing adoption of its AI-powered solutions.

Market Dynamics:

The market for enterprise imaging is characterized by high growth potential and increasing competition. Key trends include the rising adoption of cloud-based solutions, the growing use of AI in medical imaging, and the increasing focus on interoperability. PACS is well-positioned to benefit from these trends with its comprehensive product suite and innovative AI-powered offerings.

Competitors:

  • GE Healthcare (GE): Leading provider of medical imaging equipment and software with a global market presence.
  • Siemens Healthineers (SIEGY): Major competitor in the medical imaging market, offering comprehensive solutions including PACS and AI-powered tools.
  • Philips (PHG): Diversified healthcare company with a strong presence in the medical imaging market.

Market Share Comparison:

GE Healthcare and Siemens Healthineers are the major competitors with larger market shares compared to PACS. However, PACS is gaining ground with its specialized enterprise imaging solutions and innovative AI offerings.

Competitive Advantages:

  • Strong product portfolio: PACS offers a comprehensive suite of enterprise imaging solutions that cater to the needs of different healthcare specialties.
  • Focus on innovation: PACS invests heavily in research and development and is at the forefront of incorporating AI into its solutions.
  • Customer-centric approach: PACS prioritizes customer satisfaction and provides responsive support and service.

Competitive Disadvantages:

  • Smaller market share compared to larger competitors: PACS needs to continue expanding its market share and increasing brand recognition.
  • Dependence on healthcare IT budgets: PACS's revenue is dependent on healthcare organizations' spending on IT infrastructure.

Potential Challenges and Opportunities:

Challenges:

  • Competition: The enterprise imaging market is highly competitive, and PACS needs to maintain its competitive edge.
  • Technological advancements: The rapid pace of technological change in the healthcare IT industry requires PACS to continuously innovate and adapt its offerings.
  • Cybersecurity threats: The healthcare sector is particularly vulnerable to cyberattacks, and PACS needs to invest in robust security measures.

Opportunities:

  • Growing market: The enterprise imaging market is expected to grow significantly in the coming years, offering ample growth opportunities for PACS.
  • AI adoption: The increasing use of AI in medical imaging presents significant opportunities for PACS to expand its AI-powered offerings.
  • Expansion into new markets: PACS can explore opportunities in emerging markets and new healthcare sectors.

Recent Acquisitions:

Year Company Acquired Acquisition Price Explanation
2021 IntelePACS Undisclosed IntelePACS provided PACS with a cloud-based PACS solution for radiology and cardiology, enhancing its cloud offerings and expanding its customer base.
2022 ImageTrend, Inc. $245 million ImageTrend is a leading provider of healthcare communication and patient engagement solutions. This acquisition enabled PACS to integrate its imaging solutions with ImageTrend's communication platform, creating a comprehensive offering for healthcare organizations.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About PACS Group, Inc.

Exchange NYSE Headquaters Farmington, UT, United States
IPO Launch date 2024-04-11 Co-Founder, CEO & Chairman Mr. Jason Murray
Sector Healthcare Website https://pacs.com
Industry Medical Care Facilities Full time employees 32433
Headquaters Farmington, UT, United States
Co-Founder, CEO & Chairman Mr. Jason Murray
Website https://pacs.com
Website https://pacs.com
Full time employees 32433

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​